“Nearly one billion travelers pass through U.S. airports each year,” writes Alicia L. Johnson, civic science postdoctoral associate. In a new commentary, she outlines how the CDC’s genomic surveillance program, which monitors airport wastewater for traces of infectious disease, must balance public health and privacy concerns.
The work of Katalin Karikó, 2023 Nobel Prize in Medicine recipient, laid a foundation for the development of COVID-19 mRNA vaccines that saved close to 20 million lives worldwide. But her discoveries almost did not happen, writes Alicia L. Johnson, a civic science postdoctoral associate at the Baker Institute Center for Health and Biosciences. Karikó’s story highlights the vital importance of supporting women in STEM.
Some states still face challenges with racial and ethnic disparities in COVID-19 vaccine distribution, and Texas is one of them. How might we avoid these inequities in the future? The authors explain in the Baker Institute Blog.
Elena M. Marks, Varsha Varghese, Jennifer MeierMay 5, 2021
The oil glut and the unprecedented drop in demand, along with plummeting oil prices due to the coronavirus pandemic, is revealing the strengths and weaknesses of oil firms globally. The authors consider four NOCs — Ecopetrol, Petrobras, Petronas and Pemex — in the context of the current crisis.
